News25/Ratings4
News · 26 weeks63+63%
2025-12-282026-06-21
Mix4490d
- Insider22(50%)
- SEC Filings13(30%)
- Other4(9%)
- Offering3(7%)
- Leadership1(2%)
- Earnings1(2%)
Latest news
25 items- PREurope Recognizes Nature-Based Plant Improvement, Opening a New Pathway for CibusSAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) today welcomed a landmark decision by the European Union. For the first time, crops improved without adding foreign DNA will be treated like conventionally bred crops, not like transgenic GMOs. The decision opens a path for European farmers to grow cleaner crops much more productively, including for example by fighting disease and pests with far fewer chemicals, and it validates the approach Cibus has spent nearly 25 years developing. Cibus improves crops the way nature does, only far faster. Starting from a seed company's best existing varieties, Cibus can add several improvements at once, combining valuable traits li
- INSIDERCEO Wichner Craig was granted 894,309 shares (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- SECCibus Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Cibus, Inc. (0001705843) (Filer)
- PRCibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value CreationSAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced key leadership changes pursuant to the Company's previously announced succession planning strategy. As part of this plan, Craig Wichner, a board member since November 2025, has been appointed as the Company's Chief Executive Officer. Peter Beetham, who has served as the Company's Interim Chief Executive Officer, will continue his role as the Company's President and Chief Operating Officer. Concurrently, both Mr. Wichner and Dr. Beetham resigned from the Cibus Board of Directors
- SECCibus Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Cibus, Inc. (0001705843) (Filer)
- INSIDERSEC Form 4 filed by Director Finn Mark Terrence4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSEC Form 4 filed by Director Moretti August J4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSEC Form 4 filed by Director Riggs Rory B4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERDirector Prante Gerhard was granted 64,748 shares, increasing direct ownership by 161% to 104,945 units (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERDirector Lehmann Jean-Pierre Jules was granted 64,748 shares, increasing direct ownership by 9% to 763,904 units (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSEC Form 4 filed by Director Box Kimberly Ann4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSEC Form 4 filed by Director Wichner Craig4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERDirector Urban Thomas was granted 64,748 shares (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
- SECSEC Form EFFECT filed by Cibus Inc.EFFECT - Cibus, Inc. (0001705843) (Filer)
- SECSEC Form 424B3 filed by Cibus Inc.424B3 - Cibus, Inc. (0001705843) (Filer)
- SECSEC Form S-3 filed by Cibus Inc.S-3 - Cibus, Inc. (0001705843) (Filer)
- SECSEC Form 10-Q filed by Cibus Inc.10-Q - Cibus, Inc. (0001705843) (Filer)
- SECCibus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Cibus, Inc. (0001705843) (Filer)
- PRCibus Reports First Quarter Financial Results and Provides Business UpdateSAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ended March 31, 2026, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m. ET. Management Commentary Peter Beetham, Interim Chief Executive Officer of Cibus, commented, "We are pleased to report continued momentum across our priority programs during the first quarter of 2026. We continue to work with our global seed company partners to change the scale and speed of breeding. Our Rice herbicide toleranc
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Cibus Inc.SCHEDULE 13G/A - Cibus, Inc. (0001705843) (Subject)
- PRCibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and ProductionSAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of high-value plant traits, today announced the transfer of gene-edited materials for herbicide tolerance in rice to its partner, Interoc. This transition facilitates the commencement by Interoc of testing and production in anticipation of the forthcoming launch of Interoc's CIBUS® enhanced seed products into the Latin American agricultural sector. "Our collaboration with Cibus continues to deliver significant value," said Fernando De La Puente, Corporate Vice President at Interoc. "Rice is a critical crop for the Latin American eco
- PRCibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference CallSAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report first quarter 2026 financial results on Thursday, May 14, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. First Quarter 2026 Results Conference Call Event Date: Thursday, May 14, 2026 Time: 4:30 p.m. ET Participant Numbers: +1-800-274-8461 (U.S.), +1-203-518-9814 (International)The conference ID "CIBUS" or 24287 will be requir
- INSIDERAmendment: CFO Broos Carlo was granted 57,000 shares, increasing direct ownership by 59% to 154,275 units (SEC Form 4)4/A - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSEC Form 4 filed by Director Urban Thomas4 - Cibus, Inc. (0001705843) (Issuer)
- INSIDERSr VP, Research Sauer Noel was granted 38,000 shares, increasing direct ownership by 37% to 139,879 units (SEC Form 4)4 - Cibus, Inc. (0001705843) (Issuer)
CBUS FAQ
6 questionsWhere does CBUS stock trade?
Cibus Inc. (CBUS) is listed on NASDAQ.What sector and industry is CBUS in?
Cibus Inc. operates in the Industrials sector, Agricultural Chemicals industry.When did Cibus Inc. go public?
Cibus Inc. (CBUS) completed its IPO in 2017.What are analysts saying about CBUS?
Cibus Inc. has had 4 recent analyst actions on file. The most recent action was from Alliance Global Partners: Buy with a $2500.00 price target on 2024-07-29. Recent price targets range from $2200.00 to $3000.00.What companies are similar to CBUS?
Notable peers in the same industry include NTR (Nutrien Ltd.), CF (CF Industries Holdings Inc.), MOS (Mosaic Company), ICL (ICL Group Ltd.), SMG (Scotts Miracle-Gro Company). Compare CBUS side-by-side with any of them on Quantisnow.How can I track CBUS on Quantisnow?
Quantisnow aggregates Cibus Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CBUS to receive live email and push alerts on every new disclosure.